Brief: Gland Pharma Meets Q3 Consol Net Profit View
Feb 3 (Reuters) - Gland Pharma Ltd GLAD.NS :
* Q3 CONSOL NET PROFIT 2.05 BILLION RUPEES; IBES EST. 2.04
BILLION
RUPEES
* Q3 CONSOL REVENUE FROM OPERATIONS 13.84 BILLION RUPEES;
IBES
EST. 15.69 BILLION RUPEES
Further company coverage: GLAD.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant